TCRT

Boyle Kevin S. Sr.

Known title: Chief Executive OfficerCIK: 0001880600

Boyle Kevin S. Sr.'s purchase track record

Boyle Kevin S. Sr. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
11/16/2021TCRT$14K-33.3%-63.1%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

Alaunos Therapeutics (TCRT) Moves in After-Hours Trading. Alaunos Therapeutics was listed among healthcare stocks moving in Friday's after-market session. The stock is currently trading near its support level of $1.97, with an RSI of 30.4 indicating it is in oversold territory. This price action occurs within a 52-week range of $0.97 to $4.59.

this person other insiders at TCRT

Transaction History

TCRT▼ Sell$10K
TCRT▼ Sell$45K
TCRT▲ Buy$13K
TCRT▲ Buy$1K
TCRT▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.